Lavaca Capital’s CME Group CME Stock Holding History

Lavaca Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39	Closed	-$11.5K	–	361
2026 Q1	$11.5K	Hold	39	–	–	﹤0.01%	246
2025 Q4	$10.7K	Buy	39 +4	+11%	+$1.09K	﹤0.01%	253
2025 Q3	$9.46K	Buy	+35	New	+$9.52K	﹤0.01%	243

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Lavaca Capital's CME Position: Q2 2026 in Review

Lavaca Capital sold out of CME Group (CME) in Q2 2026, closing a stake of 39 shares — an estimated $11.5K sold.

Lavaca Capital first reported a position in CME in Q3 2025 and held it in 3 quarters. The position peaked at $11.5K in Q1 2026. 1,705 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Lavaca Capital reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
Lavaca Capital sold 39 CME Group shares in Q2 2026, an estimated $11.5K.
Lavaca Capital first reported a position in CME Group in Q3 2025 and held it in 3 quarters.
Lavaca Capital's CME Group position peaked at $11.5K in Q1 2026.
1,705 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.